Brief: Lipigon Appoints Johan Liwing As New CEO
Dec 16 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* SAID ON SATURDAY IT APPOINTS JOHAN LIWING AS NEW CEO FROM
DEC 16
Source text for Workspace: urn:newsml:reuters.com:*:nBQN4tVcc4
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds